AI-driven approaches present a transformative opportunity to reduce or replace animal testing in preclinical drug development. By integrating machine learning, computational biology, and multi-omics data, researchers can predict toxicity, efficacy, and pharmacokinetics with high accuracy and human relevance.
A robust CAPA system is fundamental to the quality management of therapeutic goods, biotechnology products, and medical devices.
QSN Academy is designed for a broad but clearly defined audience: organisations and individuals who seek to understand, implement, and sustain compliance through critical thinking and scientific application.
By incorporating AS 4381 methodologies into design, manufacturing, and reprocessing validation, organisations enhance both compliance efficiency and product safety.